Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 1093

    Article Cited by others


Acute liver failure after initiation of rivaroxaban: A case report and review of the literature

Baig Muhammad, Wool Kenneth J, Halanych Jewell H, Sarmad Rehan A

Year : 2015| Volume: 7| Issue : 9 | Page no: 407-410

   This article has been cited by
1 Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019
Rolf Teschke
Frontiers in Pharmacology. 2019; 10
[Pubmed]  [Google Scholar] [DOI]
2 Rivaroxaban-induced hepatotoxicity
Anna Licata,Fania Puccia,Vania Lombardo,Antonietta Serruto,Maria G. Minissale,Ilaria Morreale,Lydia Giannitrapani,Maurizio Soresi,Giuseppe Montalto,Piero L. Almasio
European Journal of Gastroenterology & Hepatology. 2018; 30(2): 226
[Pubmed]  [Google Scholar] [DOI]
3 Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions
Luca Monaco,Chiara Biagi,Valentino Conti,Mauro Melis,Monia Donati,Mauro Venegoni,Alberto Vaccheri,Domenico Motola
British Journal of Clinical Pharmacology. 2017;
[Pubmed]  [Google Scholar] [DOI]
4 Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?
Aaron Liew,James Douketis
Internal and Emergency Medicine. 2016;
[Pubmed]  [Google Scholar] [DOI]
5 RUCAM in Drug and Herb Induced Liver Injury: The Update
Gaby Danan,Rolf Teschke
International Journal of Molecular Sciences. 2015; 17(1): 14
[Pubmed]  [Google Scholar] [DOI]
6 Rivaroxaban
Reactions Weekly. 2015; 1575(1): 186
[Pubmed]  [Google Scholar] [DOI]


Read this article